Cancers 2010, 2(2), 549-566; doi:10.3390/cancers2020549
Review

Management of Melanoma Families

Received: 11 February 2010; in revised form: 12 April 2010 / Accepted: 14 April 2010 / Published: 16 April 2010
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract: In this review we have aimed to focus on the clinical management of familial melanoma patients and their relatives. Along this line three major topics will be discussed: (1) management/screening of familial melanoma families: what is advised and what is the evidence thereof; (2) variability of families worldwide with regard to clinical phenotype, including cancer spectrum and likelihood of finding germline mutations and (3) background information for clinicians on the molecular biology of familial melanoma and recent developments in this field.
Keywords: familial melanoma; hereditary melanoma; FAMMM syndrome; pancreatic carcinoma; management; surveillance; screening; DNA testing; CDKN2A
PDF Full-text Download PDF Full-Text [229 KB, uploaded 16 April 2010 10:13 CEST]

Export to BibTeX |
EndNote


MDPI and ACS Style

Bergman, W.; Gruis, N.A. Management of Melanoma Families. Cancers 2010, 2, 549-566.

AMA Style

Bergman W, Gruis NA. Management of Melanoma Families. Cancers. 2010; 2(2):549-566.

Chicago/Turabian Style

Bergman, Wilma; Gruis, Nelleke A. 2010. "Management of Melanoma Families." Cancers 2, no. 2: 549-566.

Cancers EISSN 2072-6694 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert